ADMET Predictor estimates 41 absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties from structure alone. Use it to drop compounds with likely liabilities (poor absorption, hERG blocking, mutagenicity) before you spend GPU time docking or co-folding them.
These are model predictions, not measurements. For rule-based filters (Lipinski, Veber, PAINS and other structural alerts), use Drug-likeness & Structural Alerts.
How it works
The job runs ADMET-AI 2.0.1: Chemprop-RDKit graph neural network ensembles trained on the 41 ADMET datasets of the Therapeutics Data Commons. Every run predicts all 41 endpoints; asking for fewer would not save compute. It runs on CPU.
- Classification endpoints are probabilities (0 to 1) that the molecule has the property.
- Regression endpoints use the source dataset's units, for example log(mol/L) for aqueous solubility or kcal/mol for hydration free energy.
Inputs
Up to 10,000 molecules as SMILES, InChI, or MOL blocks. Optionally add thresholds: rules such as {"endpoint": "admet_herg", "op": "lt", "value": 0.3}, all of which a molecule must pass. Molecules that can't be parsed are marked error and never pass.
Outputs
predictions.csv: one row per input molecule, one column per endpoint (admet_hia_hou,admet_herg,admet_solubility_aqsoldb, …).passers.smi: the molecules that passed every threshold (all parsed molecules when you set none).
In a workflow, every endpoint is a metric that later filter steps can rank or cut on, such as keeping molecules with admet_herg below 0.3.
Endpoints
| Group | Endpoints |
|---|---|
| Absorption | Human intestinal absorption, oral bioavailability, aqueous solubility, lipophilicity (logD7.4), hydration free energy, Caco-2 and PAMPA permeability, P-glycoprotein inhibition |
| Distribution | Blood-brain barrier penetration, plasma protein binding, volume of distribution |
| Metabolism | Inhibition of CYP1A2, 2C19, 2C9, 2D6, 3A4; CYP2C9, 2D6, 3A4 substrates |
| Excretion | Half-life, hepatocyte and microsomal clearance |
| Toxicity | hERG blocking, clinical toxicity, Ames mutagenicity, drug-induced liver injury, carcinogenicity, acute toxicity (LD50), skin reaction, and the 12 Tox21 nuclear-receptor and stress-response assays |
Limits
- Predictions are only as good as the training data: treat them as a screen, and expect lower accuracy for chemistry unlike the training sets.
- Reference percentiles against approved drugs are not included.